Regulacje i polityka gospodarcza · 18/09/2009

U.S. Government Makes Novel Rapamycin Patent Application Available for Licensing

The U.S. Government, represented by the Secretary of the Army, has made the patent application for a novel use and method of rapamycin to treat toxic shock available for non-exclusive, exclusive, or partially exclusive licensing.